A systematic review of randomized evidence for fibrinogen-depleting agents in acute ischemic stroke
Authors:
- Carl CounsellCCCarl Counsell
- Joanna WardlawJWJoanna Wardlaw
- Peter SandercockPSPeter Sandercock
- 1 January 1998
- journal article
- review article
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 7 (1) , 63-69
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Hospital management of acute ischemic stroke in ChinaJournal of Stroke and Cerebrovascular Diseases, 1997
- CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic strokeThe Lancet, 1997
- Ancrod for the treatment of acute ischemic brain infarction. The Ancrod Stroke Study Investigators.Stroke, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Experimental Ancrod (Arvin) for Acute Ischemic Stroke: Nursing ImplicationsJournal of Neuroscience Nursing, 1991
- Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid StenosisNew England Journal of Medicine, 1991
- MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosisThe Lancet, 1991
- Ancrod Causes Rapid Thrombolysis in Patients with Acute StrokeThe American Journal of the Medical Sciences, 1990
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990
- Controlled Trial of Ancrod in Ischemic StrokeArchives of Neurology, 1983